Abstract
Cancer is one of the most important diseases. It is the second leading cause of death worldwide following cardiovascular disease. There is a need to develop new chemotherapeutic agents for the treatment of cancer and it is still a significant task for medicinal chemists. Symmetrical and unsymmetrical urea derivatives have been reported to play a significant role in biological systems. Phenethylamine is a precursor of dopamine and related compounds. In this study, we disclose the first examples of phenethylamine-based urea derivatives bearing fluoro, methoxy, and methyl groups. We also report cytotoxicity and toxicity profiles of novel urea derivatives on HeLa (human cervical cancer), A549 (non-small cell lung carcinoma), and HDF (human dermal fibroblast) cell lines. Moreover, we demonstrate antioxidant properties of synthesized compounds by DPPH, ABTS, and CUPRAC method. The results revealed that 1,3-bis(4-methylphenethyl)urea was up to eightfold more potent than cisplatin against HeLa cell line and also displayed very low toxic effect on HDF cell line compared to cisplatin. On the other hand, the anticancer activity of 1-(3,4-dimethoxyphenethyl)-3-(4-fluorophenethyl)urea and 1-(3,4-dimethoxyphenethyl)-3-(4-methylphenethyl)urea were close to that of cisplatin on A549 cell line, although 1-(3,4-dimethoxyphenethyl)-3-(4-fluorophenethyl)urea was more toxic than compound 1-(3,4-dimethoxyphenethyl)-3-(4-methylphenethyl)urea on HDF cell line. All tested compounds displayed remarkable activity compared to the standard antioxidants. Considering these properties, they may be a lead compounds for the treatment of human cervical and non-small cell lung cancer. These findings may be helpful for the discovery of more biologically active phenethylamine-based urea for clinical studies.
Graphic abstract
Similar content being viewed by others
References
Chaudhary V, Das S, Nayak A, Guchhait SK, Kundu CN (2015) RSC Adv 5:26051
Sun HY, Yin MC, Hao DQ, Shen YX (2020) Appl Sci-Basel 10:2065
Gomaa SE, Friedersdorf M, El Enshasy HA, Abou-Donia MB (2020) Indones J Pharm 31:108
Toolabi M, Moghimi S, Bakhshaiesh TO, Salarinejad S, Aghcheli A, Hasanvand Z, Nazeri E, Khalaj A, Esmaeili R, Foroumadi A (2020) Eur J Med Chem 185:111786
Maria DS, Farran MA, Garcia MA, Pinilla E, Torres MR, Elguero J, Claramunt RM (2011) J Org Chem 76:6780
Sun RF, Zhang YL, Bi FC, Wang QM (2009) J Agric Food Chem 57:6356
Kishikawa K, Nakahara S, Nishikawa Y, Kohmoto S, Yamamoto M (2005) J Am Chem Soc 127:2565
Palani A, Shapiro S, McBriar MD, Clader JW, Greenlee WJ, Spar B, Kowalski TJ, Farley C, Cook J, van Heek M, Weig B, O’Neill K, Graziano M, Hawes B (2005) J Med Chem 48:4746
Pochampally J, Valeru A, Macha R, Kishorekumar A, Tigulla P, Gandu B, Gangagnirao A (2014) Pharma Chem 6:269
Krajacic MB, Peric M, Smith KS, Schonfeld ZI, Ziher D, Fajdetic A, Kujundžić N, Schönfeld W, Landek G, Padovan J, Jelić D, Ager A, Milhous WK, Ellis W, Spaventi R, Ohrt C (2011) J Med Chem 54:3595
Hwang SH, Wagner KM, Morisseau C, Liu JY, Dong H, Wecksler AT, Hammock BD (2011) J Med Chem 54:3037
Morgan BP, Muci A, Lu PP, Qian XP, Tochimoto T, Smith WW, Garard M, Kraynack E, Collibee S, Suehiro I, Tomasi A, Valdez SC, Wang W, Jiang H, Hartman J, Rodriguez HM, Kawas R, Sylvester S, Elias KA, Godinez G, Lee K, Anderson R, Sueoka S, Xu D, Wang Z, Djordjevic N, Malik FI, Morgans DJ Jr (2010) ACS Med Chem Lett 1:472
Deng XM, Wang JH, Zhang JM, Sim T, Kim ND, Sasaki T, Luther W II, George RE, Jänne PA, Gray NS (2011) ACS Med Chem Lett 2:379
Zhang J, Zhou J, Ren X, Diao Y, Li H, Jiang H, Ding K, Pei D (2012) Invest New Drugs 30:490
Anandan SK, Webb HK, Do ZN, Gless RD (2009) Bioorg Med Chem Lett 19:4259
Verlinden BK, Niemand J, Snyman J, Sharma SK, Beattie RJ, Woster PM, Birkholtz LM (2011) J Med Chem 54:6624
Sabelli HC, Mosnaim AD, Vazquez AJ, Giardina WJ, Borison RL, Pedemonte WA (1976) Biol Psychiatry 11:481
Khan HA, Ullah Q, Ahmad A, Alhomida AS, Al Rokayan SH (2016) Trace amines and neurological disorders. Academic Press, Elsevier
Manickam M, Jalani HB, Pillaiyar T, Boggu PR, Sharma N, Venkateswararao E, Lee YJ, Jeon ES, Son MJ, Woo SH, Jung SH (2018) Eur J Med Chem 143:1869
Abe H, Matsunaga S, Takekawa S, Watanabe M (2004) Preparation of indole amino acid derivatives as somatostatin agonists or antagonists. Patent WO 2004046107, Jun 3, 2004; (2004) Chem Abstr 141:23903
Berg S, Hellberg S (2003) Preparation of N-(4-methoxybenzyl)-N'-(5-nitro-1,3-thiazol-2-yl)urea for treating conditions associated with glycogen-synthase kinase-3 (GSK3). Patent WO 2003004478, Jan 16, 2003; (2003) Chem Abstr 138:106690
Gould TD, Einat H, Bhat R, Manji HK (2004) Int J Neuropsychopharmacol 7:387
Escudier B, Eisen T, Stadler WM, Szczylik C, Oudard S, Siebels M, Negrier S, Chevreau C, Solska E, Desai AA, Rolland F, Demkow T, Hutson TE, Gore M, Freeman S, Schwartz B, Shan M, Simantov R, Bukowski RM (2007) N Engl J Med 356:125
Abdel-Rahman O, Fouad M (2014) Crit Rev Oncol Hematol 91:1
Huan-Qiu L, Peng-Cheng L, Yan T, Hai-Liang Z (2009) Anti-Cancer Agents Med Chem 9:471
Boonlarppradab C, Suriyachadkun C, Supothina S, Laksanacharoen P (2016) J Antibiot 69:459
Lu CS, Tang K, Li Y, Jin B, Yin DL, Ma C, Chen XG, Huang HH (2013) Acta Pharm Sin 48:709
Chai SS, Cha BY, Kagami I, Lee YS, Sasaki H, Suenaga K, Teruya T, Yonezawa T, Nagai K, Woo JT (2011) J Antibiot 64:277
Aksu K, Ozgeris B, Taslimi P, Naderi A, Gulcin I, Goksu S (2016) Arch Pharm 349:944
Hanif M, Saleem M, Hussain MT, Rama NH, Zaib S, Aslam MAM, Jones PG, Iqbal J (2012) J Braz Chem Soc 23:854
Liou GY, Storz P (2010) Free Radic Res 44:479
Fuchs-Tarlovsky V (2013) Nutrition 29:15
Photiou A, Khan TH, Osborn HMI, Malkin H (2002) Preparation of prodrug phenylethylamine derivatives and their use in the treatment of melanoma. Patent WO 2002008174A1, Jan 31, 2002; (2002) Chem Abstr 136:150989
Lintner K (2004) Method for preparing cosmetic or dermopharmaceutical compositions comprising tyramine derivatives and use thereof. Patent WO 2004002941, Jan 8, 2004; (2004) Chem Abstr 140:77297
Yang Y, Liu Q-W, Shi Y, Song Z-G, Jin Y-H, Liu Z-Q (2014) Eur J Med Chem 84:1
Özgeriş B, Göksu S, Polat Köse L, Gülçin İ, Salmas RE, Durdagi S, Tümer F, Supuran CT (2016) Bioorg Med Chem 24:2318
Rani P, Pal D, Hegde RR, Hashim SR (2014) BioMed Res Int 2014:386473
Padiya KJ, Gavade S, Kardile B, Tiwari M, Bajare S, Mane M, Gaware V, Varghese S, Harel D, Kurhade S (2012) Org Lett 14:2814
Ozgeris B (2020) Monatsh Chem 151:1851
Reedijk J (1996) Chem Comm 7:801
Liew SK, Malagobadan S, Arshad NM, Nagoor NH (2020) Biomolecules 10:138
Perković I, Antunović M, Marijanović I, Pavić K, Ester K, Kralj M, Vlainić J, Kosalec I, Schols D, Hadjipavlou-Litina D, Pontiki E, Zorc B (2016) Eur J Med Chem 124:622
Pavan Kumar H, Kumara HK, Suhas R, Channe Gowda D (2021) Arch Pharm 354:e2000468
Chen D, Zhou X, Chen X, Huang L, Xi X, Ma C, Zhou M, Wang L, Chen T (2019) Molecules 24:2974
Vajrabhaya LO, Korsuwannawong S (2018) J Anal Sci Technol 9:15
Gülçin İ (2006) Life Sci 78:803
Gülçin İ (2006) Toxicology 217:213
Re R, Pellegrini N, Proteggente A, Pannala A, Yang M, Rice-Evans C (1999) Free Radic Biol Med 26:1231
Gülçin İ, Mshvildadze V, Gepdiremen A, Elias R (2006) Phytomedicine 13:343
Tohma HS, Gulçin I (2010) Int J Food Prop 13:657
Acknowledgements
This study was supported by Erzurum Technical University (Scientific Research Project, 2019/15).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Özgeriş, F.B., Özgeriş, B. Synthesis, characterization, and biological evaluations of substituted phenethylamine-based urea as anticancer and antioxidant agents. Monatsh Chem 152, 1241–1250 (2021). https://doi.org/10.1007/s00706-021-02830-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00706-021-02830-7